Showing session: reset
ctDNA for Cancer Stratification, Monitoring, Clonal Tracking, MRD Detection, and Early Diagnosis
- Sort by:
- Browse by:
- Permission not
granted for presentation
ctDNA and cfDNA in body fluids as cancer biomarkers
Nickolas Papadopoulos
Johns Hopkins Sidney Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
- Free
- slides video
- audio + slides
- All slides included
ctDNA monitoring in hematologic malignancies
Sarah-Jane Dawson
Peter MacCallum Cancer Center, East Melbourne, Australia
- Permission not
granted for presentation
ctDNA applications in both early and metastatic breast cancer
Carlos M Caldas
Cancer Research UK Cambridge Inst., Cambridge, United Kingdom